Atlas Trials

VNRX-5133 With VNRX-5022 in Subjects With Varying Degrees of Renal Impairment

Clinical trial NCT03690362 · COMPLETED

Trial details

NCT number
NCT03690362
Sponsor
Venatorx Pharmaceuticals, Inc.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Pharmacokinetics
Start date
2018-04-06
Primary completion
2018-11-21
Enrollment
33

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.